Back to Search

ALNY

Alnylam Pharmaceuticals, Inc.
Data: 2026-02-02
$339.11
Price
0.23%
Change
$495.55
52W High
$205.87
52W Low
Buy/Sell Forecast Trendline Why Moving Charts Options

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.

Quick Stats
Feb 02, 2026

49.5

AI Score

HOLD

1.56

Volume Ratio

Feb 12, 2026

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

ALNY Stock Summary

Last updated Feb 02, 2026

ALNY is currently trading at $339.11, positioned below its 200-day moving average of $383.43, suggesting bearish momentum. The stock has a 52-week range of $205.87 to $495.55.

Technical Analysis: The 50-day moving average stands at $401.06, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 28.629, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.028, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ALNY at 49.5/100 with a HOLD recommendation.

ALNY (Alnylam Pharmaceuticals, Inc.) Indicators

Last updated Feb 02, 2026

Indicator Value
RSI(14) 28.629
CMF (20) 0.028
ROC (10) -5.611
ADX (14) 30.848
Indicator Value
MACD (12,26,9) -16.805
AROONOSC (14) -100.0
WILLAMS %R (14) -86.076
MFI (14) 25.614
ALNY Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ALNY Price vs Max Options Open Interest
ALNY Max Change In Options Open Interest

ALNY Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ALNY Daily Out of Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ALNY Daily In the Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ALNY Most Active Options by Volume(near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Alnylam Pharmaceuticals, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

ALNY Moving Averages Analysis

ALNY (Alnylam Pharmaceuticals, Inc.) Simple Moving Averages

Moving Averages are last updated Feb 02, 2026

Days MA
10 353.84
20 369.45
30 379.46
50 401.06
100 429.8
200 383.43

ALNY Fundamental Analysis

P/E (Forward) 47.619
P/E (Trailing) 1126.8666
Market Cap ($) 44.7 billion
Earnings/Share ($) 0.3
Net Proft Margin (%) 0.0136
Dividend/Share ($) --
EPS Estimate Current Year ($) 4.7911
EPS Estimate Next Year ($) 10.5876
WallStreet Target Price ($) 477.1996
Most Recent Quarter